Remdesivir benefit in COVID-19 declines with illness severity, trial finds

The published results of a US government-backed trial show patients needing mechanical ventilation don’t benefit

The benefits of the experimental antiviral remdesivir in cutting time to recovery in patients severely ill with COVID-19 might not extend to those requiring mechanical ventilation, US researchers say.